LENZ Therapeutics annual meeting elects directors, ratifies auditor

LENZ Therapeutics, Inc.

17,983,676 of 27,544,520 shares represented at June 10, 2025 annual meeting.
Class III directors Kimberlee C. Drapkin and Zach Scheiner elected with ~12.4M and ~12.7M votes for.
Class I directors Frederic Guerard and James McCollum elected with ~15.4M and ~15.4M votes for.
Ernst & Young LLP ratified as independent auditor for FY2025 with 17,979,770 votes for.
No proposals or business items beyond standard director elections and auditor ratification.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.